GP
NKTX icon

GSK plc’s Nkarta NKTX Stock Holding History

GSK plc’s Portfolio NKTX Stock Details NKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.92M Hold
3,150,732
– – 1.48% 9
2026
Q1 		$6.65M Hold
3,150,732
– – 1.11% 12
2025
Q4 		$5.83M Buy
+3,150,732
New +$6.3M 0.73% 12

Other funds holding NKTX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GSK plc's NKTX Position: Q2 2026 in Review

GSK plc held its Nkarta (NKTX) position steady in Q2 2026 at 3,150,732 shares worth $8.92M. The position accounts for 1.48% of the portfolio, ranked #9.

GSK plc first reported a position in NKTX in Q4 2025 and has held it in 3 quarters since. 136 funds tracked by Wall St. Rank hold NKTX as of Q2 2026.

  • GSK plc held 3,150,732 shares of Nkarta worth $8.92M as of Q2 2026.
  • GSK plc left its Nkarta share count unchanged in Q2 2026.
  • Nkarta made up 1.48% of GSK plc's portfolio in Q2 2026, its #9 holding.
  • GSK plc first reported a position in Nkarta in Q4 2025 and has held it in 3 quarters since.
  • 136 funds tracked by Wall St. Rank held Nkarta as of Q2 2026.

Based on GSK plc's 13F filing for Q2 2026, filed 13 Aug 2026.